Mitsui Chemicals (4183) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
21 Nov, 2025Executive summary
Specialty chemicals domains delivered firm sales, supporting H1 FY2025 operating income before special items of ¥44.5 billion, despite impairment losses and restructuring costs, with a full-year forecast of ¥110.0 billion.
Net income attributable to owners was ¥7.8 billion in H1, impacted by non-recurring losses from business restructuring and impairment losses, with a full-year forecast of ¥55.0 billion.
A two-for-one stock split is planned with a record date of December 31, 2025, effective January 1, 2026, to broaden the investor base.
U.S. trade policies and production suspension at Omuta Works negatively impacted Mobility and Life & Healthcare Solutions, but effects were less severe than initially estimated and production is set to ramp up in 2H.
Financial highlights
H1 FY2025 sales revenue was ¥813.6 billion, down 8.6–9% year-on-year; operating income before special items fell 15.8–16% to ¥44.5 billion.
Net income attributable to owners dropped by 64.7–65% year-on-year to ¥7.8 billion, mainly due to restructuring and impairment losses.
Free cash flow in H1 was ¥69.6 billion, supporting dividends and debt repayment.
Net cash provided by operating activities increased to ¥127.2 billion, while net cash used in investing activities rose to ¥57.6 billion.
Total assets at end-September 2025 were ¥2,100.2 billion, with interest-bearing liabilities at ¥750.5 billion.
Outlook and guidance
FY2025 sales revenue is projected at ¥1,700.0 billion, revised down from ¥1,770.0 billion, mainly due to yen appreciation and lower raw material prices.
Operating income before special items is forecast at ¥110.0 billion, up 9% year-on-year; net income at ¥55.0 billion, up 71% year-on-year.
Annual dividend outlook is ¥150 per share pre-split; post-split, year-end dividend will be ¥37.5 per share.
Segment revenue guidance: Life & Healthcare Solutions up to ¥270.0 billion, Mobility Solutions down to ¥530.0 billion, ICT Solutions down to ¥280.0 billion, Basic & Green Materials down to ¥605.0 billion.
Latest events from Mitsui Chemicals
- Operating income before special items jumped 88% YoY in 1Q FY2026, led by specialty chemicals and restructuring.4183
Q1 2027 - Specialty chemicals lead profit growth as global expansion and sustainability accelerate.4183
Investor presentation - FY 2026 profit is set to rise on specialty chemicals growth and restructuring, despite external risks.4183
Q4 2026 - Profits fell on Basic & Green Materials weakness, but ICT Solutions and capital returns remain strong.4183
Q3 2026 - Profits fell on restructuring and impairment losses, but specialty chemicals remained resilient.4183
Q1 2026 - Strong YoY growth with positive outlook, but Osaka plant outage adds uncertainty.4183
Q1 2025 - H1 FY2024 profit surged 26% YoY; full-year growth expected despite plant and input cost issues.4183
Q2 2025 - FY2025 profit rebound is forecast despite net income drop and trade policy risks.4183
Q4 2025 - Profits rose on Specialty Chemicals and Mobility Solutions, offsetting Basic & Green Materials losses.4183
Q3 2025